Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar Therapy

This observational study is designed to evaluate the reported outcomes for patients
receiving topical therapy for the treatment of pain, fungal infections or skin scars. The
patients will complete the Patient Reported Outcome (PRO) survey monthly and provide
valuable data on the patients perception of their health status and well being while
receiving therapy.

Patients are enrolled for 18 months. The investigator will complete a global patient
assessment monthly of the patient's condition.

Inclusion Criteria:

1. An 18 to 85 years old (inclusive) female or male patient

2. Prescribed compound for the treatment of pain, wound healing or surface skin scar by
their Principal Investigator

3. Any systemic disease (cardiac, renal, or hepatic) must be well controlled.

4. Has no skin lesions at the site of application of study medication except for wound
under treatment

5. Able to provide informed consent

Exclusion Criteria:

1. Pregnant or lactating females or women at the child bearing potential not using
effective contraception.

2. Use of other topical or transdermal medication. Patients may be withdrawn for a
period of 2 weeks from all topical or transdermal medications prior to study
initiation.

3. Hypersensitivity to local anesthetic or other ingredients of the compounded creams to
be used in a study.

4. Prior reconstruction skin surgery or skin grafts in the area of cream application
preventing absorption of cream except for the treatment of surface skin scar

5. Chronic pain conditions not expected to respond to topical pain medication such as
deep abdominal pain, or from conditions such as cancer, or gouty arthritis.